Editorial: Diverse roles of MAP4K4 in MAP kinase signaling and its implication for cancer therapeutics.
作者信息
Roy Ruchi, Singh Sunil Kumar, Rana Ajay
机构信息
UICentre for Drug Discovery, The University of Illinois at Chicago, Chicago, IL, United States.
Department of Surgery, Division of Surgical Oncology, The University of Illinois at Chicago, Chicago, IL, United States.
出版信息
Front Oncol. 2023 Jul 19;13:1248808. doi: 10.3389/fonc.2023.1248808. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Diverse roles of MAP4K4 in MAP kinase signaling and its implication for cancer therapeutics.
Front Oncol. 2023 Jul 19;13:1248808. doi: 10.3389/fonc.2023.1248808. eCollection 2023.
2
Mitogen-activated protein kinase kinase kinase kinase 4 as a putative effector of Rap2 to activate the c-Jun N-terminal kinase.
J Biol Chem. 2004 Apr 16;279(16):15711-4. doi: 10.1074/jbc.C300542200. Epub 2004 Feb 13.
3
Map4k4 suppresses Srebp-1 and adipocyte lipogenesis independent of JNK signaling.
J Lipid Res. 2013 Oct;54(10):2697-707. doi: 10.1194/jlr.M038802. Epub 2013 Aug 7.
4
Molecular Insights of MAP4K4 Signaling in Inflammatory and Malignant Diseases.
Cancers (Basel). 2023 Apr 13;15(8):2272. doi: 10.3390/cancers15082272.
5
Suppression of MAP4K4 Signaling Ameliorates Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis-Molecular Studies Toward New Therapeutics.
J Exp Neurosci. 2019 Jul 10;13:1179069519862798. doi: 10.1177/1179069519862798. eCollection 2019.
6
MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
Tumour Biol. 2016 Aug;37(8):11457-67. doi: 10.1007/s13277-016-5022-1. Epub 2016 Mar 24.
7
MAP4K4 gene silencing in human skeletal muscle prevents tumor necrosis factor-alpha-induced insulin resistance.
J Biol Chem. 2007 Mar 16;282(11):7783-9. doi: 10.1074/jbc.M608602200. Epub 2007 Jan 16.
8
Identification of Map4k4 as a novel suppressor of skeletal muscle differentiation.
Mol Cell Biol. 2013 Feb;33(4):678-87. doi: 10.1128/MCB.00618-12. Epub 2012 Dec 3.
9
MAP4K4 expression in cardiomyocytes: multiple isoforms, multiple phosphorylations and interactions with striatins.
Biochem J. 2021 Jun 11;478(11):2121-2143. doi: 10.1042/BCJ20210003.
10
MAP4K4 promotes pancreatic tumorigenesis via phosphorylation and activation of mixed lineage kinase 3.
Oncogene. 2021 Oct;40(43):6153-6165. doi: 10.1038/s41388-021-02007-w. Epub 2021 Sep 13.
本文引用的文献
1
MAP4K4 deletion inhibits proliferation and activation of CD4(+) T cell and promotes T regulatory cell generation in vitro.
Cell Immunol. 2014 May-Jun;289(1-2):15-20. doi: 10.1016/j.cellimm.2014.02.006. Epub 2014 Mar 11.
2
Rap1 and Rap2 antagonistically control endothelial barrier resistance.
PLoS One. 2013;8(2):e57903. doi: 10.1371/journal.pone.0057903. Epub 2013 Feb 28.
3
ShRNA-targeted MAP4K4 inhibits hepatocellular carcinoma growth.
Clin Cancer Res. 2011 Feb 15;17(4):710-20. doi: 10.1158/1078-0432.CCR-10-0331. Epub 2010 Dec 30.
4
Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.
Clin Cancer Res. 2008 Nov 1;14(21):7043-9. doi: 10.1158/1078-0432.CCR-08-0381.
5
A small interfering RNA screen for modulators of tumor cell motility identifies MAP4K4 as a promigratory kinase.
Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3775-80. doi: 10.1073/pnas.0600040103. Epub 2006 Feb 28.
6
The STE20 kinase HGK is broadly expressed in human tumor cells and can modulate cellular transformation, invasion, and adhesion.
Mol Cell Biol. 2003 Mar;23(6):2068-82. doi: 10.1128/MCB.23.6.2068-2082.2003.
Zotero 插件